{{PBB|geneid=4137}}
'''Tau蛋白'''（{{lang-en|Tau proteins}}），又譯濤蛋白<ref>{{cite journal | title = 阿茲海默症的成因及治療 | url = http://www.taiwan-pharma.org.tw/JTP/120/068-073.html | author = 楊雨哲, 孫承洲 | volume = 30 | number = 3 | issn = 22206493 | date = 2014-09-30 | accessdate = 2015-01-23 | deadurl = yes | archiveurl = https://web.archive.org/web/20150123201041/http://www.taiwan-pharma.org.tw/JTP/120/068-073.html | archivedate = 2015-01-23 }}</ref>。是一种[[微管相关蛋白|微管相关蛋白]]，在[[中枢神经系统|中枢神经系统]]的[[神经元|神经元]]非常丰富而少见于其它细胞，在中枢神经系统的[[星形胶质细胞|星形胶质细胞]]和[[少突胶质细胞|少突胶质细胞]]中表达量也很低<ref name="pmid1903170">{{cite journal | author = Shin RW, Iwaki T, Kitamoto T, Tateishi J | title = Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues | journal = Lab. Invest. | volume = 64 | issue = 5 | pages = 693–702 | pmid = 1903170 | doi = |date=May 1991}}</ref>。tau蛋白有缺陷并不再正常稳定[[微管|微管]]时，可导致[[神经系统|神经系统]]病变和[[失智症|失智症]]，如[[阿兹海默病|阿兹海默病]]。

tau蛋白的多种蛋白异型体是由单个[[基因|基因]]（人类基因组中为'''''MAPT'''''，microtubule-associated protein tau，微管相关蛋白tau）mRNA的[[選擇性剪接|選擇性剪接]]而形成的<ref name="pmid3131773">{{cite journal | author = Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A | title = Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 85 | issue = 11 | pages = 4051–5 | pmid = 3131773 | pmc = 280359 | doi = 10.1073/pnas.85.11.4051 |date=June 1988}}</ref><ref name="pmid2484340">{{cite journal | author = Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA | title = Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | journal = Neuron | volume = 3 | issue = 4 | pages = 519–26 | pmid = 2484340 | doi = 10.1016/0896-6273(89)90210-9| url =  |date=October 1989}}</ref>。1975年，它们由[[Marc_Kirschner|Marc Kirschner]]在[[普林斯顿大学|普林斯顿大学]]的实验室中发现<ref name="pmid1057175">{{cite journal | author = Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW | title = A protein factor essential for microtubule assembly | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 72 | issue = 5 | pages = 1858–62 | pmid = 1057175 | pmc = 432646 | doi = 10.1073/pnas.72.5.1858 |date=May 1975}}</ref>。

== 功能 ==
tau蛋白是一种高度可溶的[[微管相关蛋白|微管相关蛋白]]（MAP）。与非神经元细胞相较，人体内tau更多地在神经元内发现。tau蛋白的主要功能之一是维持轴突微管的稳定性。而其它神经系统中的MAPs家族蛋白也有着相似的功能，这体现在tau敲除的小鼠并没有发现其脑组织的发育受到影响。这可能是在tau缺失后，其它MAPs家族蛋白在神经元内起到代偿tau的作用，从而继续维持轴突微管的稳定，保证脑功能的正常运作。<ref name="pmid8202139">{{cite journal | author = Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N | title = Altered microtubule organization in small-calibre axons of mice lacking tau protein | journal = Nature | volume = 369 | issue = 6480 | pages = 488–91 | pmid = 8202139 | doi = 10.1038/369488a0 |date=June 1994}}</ref> tau并不在[[树突|树突]]发挥功能，而主要作用在[[轴突|轴突]]远端维持微管的稳定性和必要的灵活性。这与MAP6蛋白（位于轴突近端固定微管）与MAP2（主要维持树突的稳定性）的功能相对。

Tau蛋白与微管蛋白（[[Tubulin|Tubulin]]）相互作用以稳定微管，同时驱动Tubulin在微管内组装。Tau蛋白通过异构和磷酸化控制微管的稳定性。

== 结构 ==
六tau蛋白异构体存在于人类脑部组织中，以在结合区域中的编号为标识。其中三个异构体拥有三个结合区域，其余三个异构体则有四个。此结合区域位于该蛋白的[[羟基末端|羟基末端]]并带有正电（可与带负电的微管结合）。而带有四个结合区域的异构体有更好的稳定微管的功能。此异构体则为tau基因的2、3和10号[[外显子|外显子]]被[[选择性剪切|选择性剪切]]的产物。

tau蛋白可视为一个在最长的tau蛋白异构体上拥有79个[[丝氨酸|丝氨酸]]和[[苏氨酸|苏氨酸]]磷酸化位点的[[磷酸蛋白|磷酸蛋白]]。有报道称磷酸蛋白在普通tau蛋白的这些位点上的数量已达到30个左右。

磷酸蛋白同时也受[[激酶|激酶]]宿主的控制，包括PKN（[[丝氨酸/苏氨酸蛋白激酶|丝氨酸/苏氨酸蛋白激酶]]）。当PKN被激活，便会磷酸化tau蛋白从而造成微管组织破坏。

tau蛋白的磷酸蛋白也被先天性地控制。例如婴儿中枢神经系统的tau蛋白的磷酸化程度比成人的更高。而所有异构体中的磷酸化程度由于磷酸酶的作用会随着人年龄的增长而减弱。比如激酶，磷酸酶也在对这个tau蛋白的磷酸蛋白的调节中起到作用。

== 基因 ==

== 临床意义 ==
tau蛋白（tau包含物，pTau）的{{le|过度磷酸化|Hyperphosphorylation}}可导致配对的螺旋丝和直丝的缠结的[[自组装|自组装]]，其参与[[阿茲海默症|阿茲海默症]]，[[额颞叶痴呆|额颞叶痴呆]]，和其他tau蛋白病的发病机理<ref name="pmid11381127">{{cite journal | vauthors = Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K | title = Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 98 | issue = 12 | pages = 6923–8  | date = June 2001 | pmid = 11381127 | pmc = 34454 | doi = 10.1073/pnas.121119298 }}</ref>。

== 脑损伤 ==

== 相互作用 ==






==另见==
* [[Tau蛋白病变|Tau蛋白病变]]，一类与tau蛋白积累有关的疾病
* [[拳击员痴呆|拳击员痴呆]]
* [[阿兹海默病|阿兹海默病]]
* [[皮质基地变性|皮质基地变性]]
* {{进行性核上性麻痹}}
* [[蛋白质构象病|蛋白质构象病]]
* [[皮克氏病|皮克氏病]]
* [[17号染色体额颞叶痴呆症和帕金森氏症|17号染色体额颞叶痴呆症和帕金森氏症]]
* [[朊病毒|朊病毒]]
*[[Chronic_traumatic_encephalopathy(CTE)(慢性創傷性腦病變)|Chronic traumatic encephalopathy(CTE)(慢性創傷性腦病變)]]

== 参考文献 ==
{{Reflist | colwidth=35em}}

==进一步阅读==
{{refbegin | colwidth=35em}}
*{{cite journal  | author=Goedert M, Crowther RA, Garner CC |title=Molecular characterization of microtubule-associated proteins tau and MAP2 |journal=Trends Neurosci. |volume=14 |issue= 5 |pages= 193–9 |year= 1991 |pmid= 1713721 |doi=10.1016/0166-2236(91)90105-4  }}
*{{cite journal  | author=Morishima-Kawashima M, Hasegawa M, Takio K, ''et al.'' |title=Hyperphosphorylation of tau in PHF |journal=Neurobiol. Aging |volume=16 |issue= 3 |pages= 365–71; discussion 371–80 |year= 1995 |pmid= 7566346 |doi=10.1016/0197-4580(95)00027-C  }}
*{{cite journal  | author=Heutink P |title=Untangling tau-related dementia |journal=Hum. Mol. Genet. |volume=9 |issue= 6 |pages= 979–86 |year= 2000 |pmid= 10767321 |doi=10.1093/hmg/9.6.979  }}
*{{cite journal  | author=Goedert M, Spillantini MG |title=Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease |journal=Biochim. Biophys. Acta |volume=1502 |issue= 1 |pages= 110–21 |year= 2000 |pmid= 10899436 |doi=  10.1016/S0925-4439(00)00037-5}}
*{{cite journal  | author=Morishima-Kawashima M, Ihara Y |title=[Recent advances in Alzheimer's disease] |journal=Seikagaku |volume=73 |issue= 11 |pages= 1297–307 |year= 2002 |pmid= 11831025 |doi=  }}
*{{cite journal  | author=Blennow K, Vanmechelen E, Hampel H |title=CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease |journal=Mol. Neurobiol. |volume=24 |issue= 1–3 |pages= 87–97 |year= 2002 |pmid= 11831556 |doi=10.1385/MN:24:1-3:087  }}
*{{cite journal  | author=Ingram EM, Spillantini MG |title=Tau gene mutations: dissecting the pathogenesis of FTDP-17 |journal=Trends in molecular medicine |volume=8 |issue= 12 |pages= 555–62 |year= 2003 |pmid= 12470988 |doi=10.1016/S1471-4914(02)02440-1  }}
*{{cite journal  | author=Pickering-Brown S |title=The tau gene locus and frontotemporal dementia |journal=Dementia and geriatric cognitive disorders |volume=17 |issue= 4 |pages= 258–60 |year= 2004 |pmid= 15178931 |doi= 10.1159/000077149 }}
*{{cite journal  | author=van Swieten JC, Rosso SM, van Herpen E, ''et al.'' |title=Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17 |journal=Dementia and geriatric cognitive disorders |volume=17 |issue= 4 |pages= 261–4 |year= 2004 |pmid= 15178932 |doi= 10.1159/000077150 }}
*{{cite journal  | author=Kowalska A, Jamrozik Z, Kwieciński H |title=Progressive supranuclear palsy--parkinsonian disorder with tau pathology |journal=Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences |volume=42 |issue= 2 |pages= 119–23 |year= 2004 |pmid= 15266787 |doi=  }}
*{{cite journal  | author=Rademakers R, Cruts M, van Broeckhoven C |title=The role of tau (MAPT) in frontotemporal dementia and related tauopathies |journal=Hum. Mutat. |volume=24 |issue= 4 |pages= 277–95 |year= 2005 |pmid= 15365985 |doi= 10.1002/humu.20086 }}
*{{cite journal  | author=Lee HG, Perry G, Moreira PI, ''et al.'' |title=Tau phosphorylation in Alzheimer's disease: pathogen or protector? |journal=Trends in molecular medicine |volume=11 |issue= 4 |pages= 164–9 |year= 2005 |pmid= 15823754 |doi= 10.1016/j.molmed.2005.02.008 }}
*{{cite journal  | author=Hardy J, Pittman A, Myers A, ''et al.'' |title=Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens |journal=Biochem. Soc. Trans. |volume=33 |issue= Pt 4 |pages= 582–5 |year= 2005 |pmid= 16042549 |doi= 10.1042/BST0330582 }}
*{{cite journal  | author=Deutsch SI, Rosse RB, Lakshman RM |title=Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications |journal=Prog. Neuropsychopharmacol. Biol. Psychiatry |volume=30 |issue= 8 |pages= 1369–80 |year= 2007 |pmid= 16793187 |doi= 10.1016/j.pnpbp.2006.04.007 }}
*{{cite journal  | author=Williams DR |title=Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau |journal=Internal medicine journal |volume=36 |issue= 10 |pages= 652–60 |year= 2006 |pmid= 16958643 |doi= 10.1111/j.1445-5994.2006.01153.x }}
*{{cite journal  | author=Pittman AM, Fung HC, de Silva R |title=Untangling the tau gene association with neurodegenerative disorders  | series=15 |journal=Hum. Mol. Genet. |volume=Spec No 2 |issue=  Review Issue 2|pages= R188–95 |year= 2006 |pmid= 16987883 |doi= 10.1093/hmg/ddl190 }}
*{{cite journal  | author=Roder HM, Hutton ML |title=Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease |journal=Expert Opin. Ther. Targets |volume=11 |issue= 4 |pages= 435–42 |year= 2007 |pmid= 17373874 |doi= 10.1517/14728222.11.4.435 }}
*{{cite journal  | author=van Swieten J, Spillantini MG |title=Hereditary frontotemporal dementia caused by Tau gene mutations |journal=Brain Pathol. |volume=17 |issue= 1 |pages= 63–73 |year= 2007 |pmid= 17493040 |doi= 10.1111/j.1750-3639.2007.00052.x }}
*{{cite journal  | author=Caffrey TM, Wade-Martins R |title=Functional MAPT haplotypes: bridging the gap between genotype and neuropathology |journal=Neurobiol. Dis. |volume=27 |issue= 1 |pages= 1–10 |year= 2007 |pmid= 17555970 |doi= 10.1016/j.nbd.2007.04.006  | pmc=2801069 }}
* {{cite journal | author = Delacourte A | title = Tauopathies: recent insights into old diseases | journal = Folia Neuropathol | volume = 43 | issue = 4 | pages = 244–57 | year = 2005 | pmid = 16416389 | doi = | url =  }}
* {{cite journal | author = Hirokawa N, Shiomura Y, Okabe S | title = Tau proteins: the molecular structure and mode of binding on microtubules | journal = J. Cell Biol. | volume = 107 | issue = 4 | pages = 1449–59 | pmid = 3139677 | pmc = 2115262 | doi = 10.1083/jcb.107.4.1449| url =https://archive.org/details/sim_journal-of-cell-biology_1988-10_107_4/page/1449|date=October 1988}}
{{refend}}

==外部链接==
* {{MeshName|tau+Proteins}}
* [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ftdp-17  GeneReviews/NCBI/NIH/UW entry on MAPT-Related Disorders]{{Wayback|url=http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ftdp-17 |date=20100601182515 }}
* [https://web.archive.org/web/20131203022442/http://rad.usuhs.edu/medpix/kiosk_image.html?mode=pt&pt_id=13421#pic MR scans of variant CJD] CSF Tau positive man

{{细胞骨架蛋白}}

{{DEFAULTSORT:Tau Protein}}